Trial Profile
Clinical Trials Insight: 700054126
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 01 Mar 2010
Price :
$35
*
At a glance
- Drugs Granisetron (Primary)
- Indications Nausea; Vomiting
- Focus Registrational; Therapeutic Use
- 01 Mar 2010 New trial record.